Use of Alzheimer disease biomarkers: potentially yes for clinical trials but not yet for clinical practice
- PMID: 19622825
- PMCID: PMC2792581
- DOI: 10.1001/jama.2009.1073
Use of Alzheimer disease biomarkers: potentially yes for clinical trials but not yet for clinical practice
Comment on
-
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.JAMA. 2009 Jul 22;302(4):385-93. doi: 10.1001/jama.2009.1064. JAMA. 2009. PMID: 19622817
References
-
- Mattsson N, Zetterberg H, Hansson O, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA. 2009;302(4):385–393. - PubMed
-
- Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–308. - PubMed
-
- Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Archives of Neurology. 2001;58:1985–1992. - PubMed
-
- Petersen RC. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine. 2004;256:183–194. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical